Results 291 to 300 of about 168,140 (338)

Comparison of neoadjuvant chemotherapy plus immunotherapy versus chemoradiotherapy for esophageal squamous cell carcinoma patients: efficacy and safety outcomes. [PDF]

J Thorac Dis
Shi S, Li L, Zhou H, Xu F, Liu N, Zhang D, Yuan S.   +6 more
europepmc   +1 more source

Long‐term quality of life in patients with bladder cancer following radical cystectomy

BJU International, Volume 135, Issue 4, Page 675-683, April 2025.
Objectives To investigate changes in quality of life (QoL) up to 8 years after radical cystectomy (RC) and compare QoL after RC with a gender‐ and age‐matched Dutch normative population. Furthermore, we aimed to identify patient characteristics associated with QoL and QoL trajectories after RC.
Emine Akdemir, Martijn M. Stuiver, Maaike W. van de Kamp, Jolanda Bloos ‐ van der Hulst, Laura S. Mertens, Kees Hendricksen, Wim H. van Harten, Anne M. May, Maike G. Sweegers   +8 more
wiley   +1 more source

Shortcoming of ypStage staging system: Lack of differentiation for preoperative treatment. [PDF]

PLoS One
Du P, Zhou J, Liu P, Huang G, Hu C.
europepmc   +1 more source

Ligand‐Receptor Interactions Between Squamous and Endothelial Cells Induce Head and Neck Squamous Cell Carcinoma

Cancer Science, EarlyView.
SCC develops via ligand‐receptor molecular interactions between squamous epithelial and vascular endothelial cells in IPCLs. ABSTRACT Advances in narrowband imaging (NBI) have revealed that squamous epithelial lesions form alongside changes in squamous epithelial cells and intrapapillary capillary loops (IPCLs) in the head and neck.
Takahiro Ishiyama, Daisuke Sano, Hideaki Takahashi, Nobuhiko Oridate, Yutaka Suzuki, Satoshi Fujii   +5 more
wiley   +1 more source

Neoadjuvant chemotherapy with albumin-bound paclitaxel plus cisplatin and capecitabine for locally advanced esophageal squamous cell carcinoma: a phase 2 clinical trial. [PDF]

Int J Surg
Zhang W, Chen X, Xue L, Jiang Z, Qu D, Yang Z, Qin J, Wang Z, Zhang M, Li Y, Zhou A, Gao S.   +11 more
europepmc   +1 more source

The immune-related microRNA miR-146b is upregulated in glioblastoma recurrence [PDF]

, 2018
Badiyan, Shahed N, Cai, Chunyu, Huang, Jiayi, Khwaja, Shariq S, Wang, Xiaowei   +4 more
core   +1 more source

Polo‐Like Kinase 1 Expression in Colorectal Cancer: Association With RAS Mutations

Cancer Science, EarlyView.
PLK1 expression may serve as a biomarker for adjuvant chemotherapy resistance in CRC. This study focused on the relationship between PLK1 expression and RAS mutation, which has been reported to be highly sensitive to PLK1 inhibitors. RAS mutation with high PLK1 expression predicts poorer survival in adjuvant‐treated CRC patients.
Yasushi Tanaka, Eiji Oki, Ryota Nakanishi, Tetsuro Kawazoe, Kensuke Kudo, Yoko Zaitsu, Yuichi Hisamatsu, Koji Ando, Yoshinao Oda, Tomoharu Yoshizumi   +9 more
wiley   +1 more source

Development and validation a radiomics combined clinical model predicts treatment response for esophageal squamous cell carcinoma patients. [PDF]

BMC Gastroenterol
Yin X, Cui Y, Liu T, Li Z, Liu H, Ma X, Sha X, Ma C, Han D, Yin Y.   +9 more
europepmc   +1 more source

PC4 Potentially Predicts Chemoradiation‐Induced Antitumor Immunity in Esophageal Squamous Cell Carcinoma

Cancer Science, EarlyView.
In present study, we describe the tumor‐infiltrating CD8+T cells pattern induced by neoadjuvant chamoradiation (CRT) in human esophageal squamous cell carcinoma (ESCC), and reveal that PC4 expression predicted CRT‐induced antitumor immune response with high probability and may help stratify subgroups with better prognosis in patients with locally ...
Jieyong Tian, Xiaoying Wei, Huiquan Liu, Qingsong Pang, Dong Qian, Haiming Dai   +5 more
wiley   +1 more source

Clinical efficacy of different neoadjuvant therapies for resectable esophageal squamous cell carcinoma. [PDF]

World J Surg Oncol
Wang X, Wen D, Feng H, Luo M.
europepmc   +1 more source